Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC). [PDF]
J Exp Clin Cancer Res, 2023 Lee SY +22 more
europepmc +1 more source
Treatment Algorithm for Advanced ALK-Rearranged NSCLC: Reply [PDF]
Journal of Thoracic Oncology, 2020 Fei, Zhou, Caicun, Zhou
openaire +2 more sources
Overview ofALKandROS1Rearranged Lung Cancer
Tuberculosis and Respiratory Diseases, 2013 Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic ...
openaire +2 more sources
Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma. [PDF]
J Cancer Res Clin Oncol, 2022 Xie X +5 more
europepmc +1 more source
Multiple Primary Lung Cancers With ALK Rearrangement: A Case Report and Literature Review. [PDF]
Front Oncol, 2022 Huimin Z +6 more
europepmc +1 more source
Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports. [PDF]
Front Oncol, 2023 Shi L +7 more
europepmc +1 more source
Expression of Concern: A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients. [PDF]
PLoS One, 2023 PLOS ONE Editors.
europepmc +1 more source